CDC Website CDC Website

To Join the NPIN community or

Home » Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)

COVID-19: General Information | Testing | Vaccines |

Contact Organizations directly about changes to services or hours

Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to encourage pilot and/or feasibility research in the following areas: 1) the development and pilot testing of new or adapted interventions to prevent or delay the initiation of substance use and/or the progression from use to misuse or disorder and 2) pre-trial feasibility and acceptability testing of services and service system research relevant to the prevention of substance use. In addition to the prevention of substance use, misuse and disorder, other outcomes of interest for the research supported through FOA include a reduction in negative sequalae such as deaths related to impaired driving, suicidal behavior (e.g., nonfatal and fatal attempts), and drug- or alcohol-related acquisition or transmission of HIV infection and viral hepatitis among diverse populations and settings.

Application Due Date
2/16/21
Project Start Date
12/1/21
Application Contact
Penny
Greene
Grants Management Specialist
301-827-6845
Penny.Greene@nih.gov
Technical Contact
Amy B.
Goldstein, PhD
Chief, Prevention Research Branch
amy.goldstein@nih.gov
301-827-4124
Fund Duration
The maximum project period is 3 years.
Subjects
Audiences

Fund Number: 

353374

Fund ID: 

PA-21-110

Last modified: 

1/19/21